CStone PharmaceuticalsHKEX: 2616

Voluntary announcement - increase in shareholding by CEO and executive director dr. jianxin yang by 496,000 shares, with accumulated purchase totaling 14,210,500 shares

· Issued by CStone Pharmaceuticals via HKEXnews

Filed with HKEX · Stock code 2616 · · 2 pages · English

The forward-looking statements made in this announcement relate only to the events or information as of the date on which the statements are made in this announcement. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made o

CStone Pharmaceuticals on 6ix

Earlier from CStone Pharmaceuticals

Later from CStone Pharmaceuticals

All CStone Pharmaceuticals news releases